Allergan plc (NYSE:AGN)
| 186.37 Delayed Data As of Dec 06 |  +0.29 / +0.16%Today’s Change | 114.27 Today|||52-Week Range 186.91 | +39.44% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 3.9B | 15.0B | -4.7B | -5.1B | |
| Depreciation | 5.6B | 6.6B | 7.4B | 6.7B | ||
| Total Other Cash Flow | 3.7B | -18.0B | 10.0B | 6.5B | ||
| Funds From Operations | 5.8B | 2.2B | 4.9B | 6.9B | ||
| Funds From/For Other Operating Expenses | 1.3B | 726.5M | -933.9M | 1.3B | ||
| Net Cash Flow - Operating Activities | 4.5B | 1.4B | 5.9B | 5.6B | ||
| Investing | Increase In Investments | -24.3M | -15.7B | -9.8B | -2.5B | |
| Decrease In Investments | 883.0M | 0.00 | 0.00 | -- | ||
| Capital Expenditures | -454.9M | -331.4M | -349.9M | -253.5M | ||
| Fixed Asset Disposal | 140.1M | 33.8B | 7.1M | 30.4M | ||
| Net Assets From Acquisitions | -37.5B | -1.2B | -5.3B | 0.00 | ||
| Other Investing - Uses | 0.00 | 0.00 | 0.00 | -466.0M | ||
| Other Investing - Sources | -- | 7.8B | 15.2B | 6.3B | ||
| Net Cash Flow Investing | -37.1B | 24.3B | -878.0M | 3.1B | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 29.8B | 1.1B | 3.5B | 2.6B | ||
| Long Term Debt Reduction | -5.1B | -10.8B | -6.4B | -8.8B | ||
| Net Proceeds Stock Sale | 9.2B | 172.1M | 183.4M | 102.4M | ||
| Common Preferred Redeemed | -118.0M | -15.1B | -493.0M | -2.8B | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | -1.0B | ||
| Cash Dividends Paid - Total | -208.1M | -278.4M | -1.2B | -1.0B | ||
| Other Sources - Financing | 76.1M | 20.4M | 0.00 | 465.5M | ||
| Other Uses - Financing | 230.1M | 161.1M | 511.6M | 264.9M | ||
| Net Cash Flow - Financing | 33.4B | -25.1B | -4.9B | -9.7B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -6.5M | -8.5M | 21.4M | 4.7M | |
| Net Change In Cash | 852.5M | 636.5M | 71.8M | -941.5M | ||
